Takeda Pharmaceutical Company Limited acquired 791,100 shares of treasury stock on July 10, 2024, at approximately 2.8 billion yen. The acquired shares are scheduled to be canceled on the same day, July 31, 2024.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9746","jir_company_name":"Takeda Pharmaceutical Company Limited","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/9746-20260713-01.pdf","jir_short_summary":"Takeda Pharmaceutical Company Limited acquired 791,100 shares of treasury stock on July 10, 2024, at approximately 2.8 billion yen. The acquired shares are scheduled to be canceled on the same day, July 31, 2024.","jir_summary":"### Overview of Share Buyback and Cancellation\nTakeda Pharmaceutical Company Limited acquired 791,100 shares of treasury stock on July 10, 2024, for approximately 2.8 billion yen. The shares were acquired through the Tokyo Stock Exchange\u2019s off-market buyback trading system (ToSTNeT-3), and are scheduled to be canceled on July 31, 2024. This will reduce the number of issued shares, aiming to enhance shareholder value.\n\n### Future Outlook and Impact on Shareholders\nThis share buyback and cancellation was conducted as part of shareholder return measures, likely to suppress share dilution and improve per-share value. The total purchase amount is within a limit of 3,190,500,000 yen, with ongoing expectations for continued improvements in capital efficiency and shareholder returns.","jir_financial_highlights":"Total number of shares acquired: 791,100 shares (Unknown)\nAcquisition price: 3,545 yen per share (Unknown)\nTotal amount of purchase: 2,804,449,500 yen (Unknown)","jir_category":"","jir_hashtags":"#TakedaPharmaceutical, #ShareBuyback, #JapaneseStocks","jir_key_figures":"Number of shares acquired: 791,100 shares\nAcquisition price: 3,545 yen per share\nTotal purchase amount: 2,804,449,500 yen","jir_meta_title":"\u3010Takeda Pharmaceutical Company Limited\u3011Share Buyback and Cancellation | July 2024","jir_meta_description":"Takeda Pharmaceutical Company Limited acquired 791,100 shares of treasury stock in July 2024 and completed cancellation on the same day. Implemented measures to improve capital efficiency.","jir_og_title":"\u3010Takeda Pharmaceutical Company Limited\u3011Share Buyback and Cancellation | July 2024","jir_og_description":"Takeda Pharmaceutical Company Limited conducted a share buyback and cancellation. Implemented measures aimed at shareholder returns and capital efficiency improvements.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8928,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-79576","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n